Testing effectiveness (Phase 2)WithdrawnNCT00343759
What this trial is testing
Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy
Who this might be right for
Breast Cancer
University of Pennsylvania